- Home
- VERO vs XXII Comparison
VERO vs XXII Comparison
Compare VERO & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- XXII
- Stock Information
- Founded
- VERO N/A
- XXII 1998
- Country
- VERO Canada
- XXII United States
- Employees
- VERO N/A
- XXII N/A
- Industry
- VERO Medical/Dental Instruments
- XXII Medicinal Chemicals and Botanical Products
- Sector
- VERO Health Care
- XXII Health Care
- Exchange
- VERO Nasdaq
- XXII Nasdaq
- Market Cap
- VERO 2.2M
- XXII 2.1M
- IPO Year
- VERO N/A
- XXII N/A
- Fundamental
- Price
- VERO $2.20
- XXII $1.08
- Analyst Decision
- VERO
- XXII
- Analyst Count
- VERO 0
- XXII 0
- Target Price
- VERO N/A
- XXII N/A
- AVG Volume (30 Days)
- VERO 92.7K
- XXII 603.9K
- Earning Date
- VERO 05-15-2025
- XXII 05-13-2025
- Dividend Yield
- VERO N/A
- XXII N/A
- EPS Growth
- VERO N/A
- XXII N/A
- EPS
- VERO N/A
- XXII N/A
- Revenue
- VERO $60,997,000.00
- XXII $23,869,000.00
- Revenue This Year
- VERO N/A
- XXII $19.23
- Revenue Next Year
- VERO $7.55
- XXII $81.05
- P/E Ratio
- VERO N/A
- XXII N/A
- Revenue Growth
- VERO N/A
- XXII N/A
- 52 Week Low
- VERO $2.16
- XXII $0.70
- 52 Week High
- VERO $17.49
- XXII $226.80
- Technical
- Relative Strength Index (RSI)
- VERO 42.60
- XXII 47.15
- Support Level
- VERO $2.34
- XXII $1.06
- Resistance Level
- VERO $2.56
- XXII $1.26
- Average True Range (ATR)
- VERO 0.15
- XXII 0.17
- MACD
- VERO -0.00
- XXII 0.04
- Stochastic Oscillator
- VERO 19.57
- XXII 49.25
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.